Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03680846
Other study ID # CA2018-2 US NSRBP
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 5, 2018
Est. completion date November 2022

Study information

Verified date October 2021
Source Nevro Corp
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being conducted to document the safety, clinical effectiveness and cost-effectiveness of high-frequency SCS at 10 kHz (HF10™ Therapy) delivered through the Senza system in subjects with chronic refractory back pain (with or without leg pain) who are not considered candidates for spine surgery. This study is a multi-center, prospective, randomized study to compare the two treatment groups.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 211
Est. completion date November 2022
Est. primary completion date October 6, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Key Inclusion Criteria: 1. Have been diagnosed with chronic, refractory axial low back pain with a neuropathic component and are not eligible for spine surgery 2. Have not had any surgery for back or leg pain, or any surgery resulting in back or leg pain 3. Qualifying pain score 4. Be on stable pain medications, as determined by the Investigator 5. Be willing and capable of giving informed consent 6. Be willing and able to comply with study-related requirements, procedures, and visits 7. Be capable of subjective evaluation, able to read and understand written questionnaires in the local language and are able to read, understand and sign the written inform consent Key Exclusion Criteria: 1. Have a diagnosed back condition with inflammatory causes of back pain, serious spinal pathology and/or neurological disorders 2. Have a medical condition or pain in other area(s), not intended to be treated in this study 3. Any diagnosis or known condition that can impact reporting of study outcomes as determined by the Investigator 4. Be benefitting within 30 days prior to enrollment from an interventional procedure to treat back and/or leg pain 5. Have any addictions as determined by the Investigator 6. Have an existing drug pump and/or SCS system or another active implantable device such as a pacemaker 7. Have prior experience with neuromodulation devices 8. Other general exclusions applicable for SCS devices 9. Be involved in an injury claim under current litigation 10. Have a pending or approved worker's compensation claim

Study Design


Related Conditions & MeSH terms


Intervention

Device:
HF10 Therapy
Senza 10 kHz Spinal Cord Stimulation
Other:
CMM
Conventional Medical Management

Locations

Country Name City State
United States Nevro Corp Redwood City California

Sponsors (1)

Lead Sponsor Collaborator
Nevro Corp

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Observational Outcomes on reduction in pain using a 10 cm Visual Analog Scale (VAS) Percentage change in back pain 24 months
Other Observational Outcomes on disability using Oswestry Disability Index scores Percentage change from Baseline in ODI score 24 months
Other Observational Outcomes on Health related quality of life evaluation as measured by the 5 dimension EuroQol EQ-5D-5L questionnaire Change in quality of life index compared to baseline 24 months
Primary Difference between treatment groups in responder rates. Responder is defined as a subject who has at least 50% reduction in pain from Baseline as assessed by a 10 cm Visual Analog Scale (VAS) 3 Months
Secondary Change in Disability as Measured by Oswestry Disability Index Percentage of subjects with at least 10 point decrease from Baseline in Oswestry Disability Index (ODI) score 6 months
Secondary Percentage change from baseline in back pain intensity (as assessed by VAS) 6 months
Secondary Changes in Quality of Life (QOL) as measured by EuroQol EQ-5D-5L questionnaire It measures the subject's health state as assessed in 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) each with 5 levels. In addition there is an EQ VAS which records the patient's self-rated health on a vertical visual analogue scale. The scores on these five dimensions can be presented as a health profile or can be converted to a single number summary called the "index value". 6 months
Secondary Global impression of change Proportion of subjects reporting "better" or "great deal better" on the Patient Global Impression of Change (PGIC) questionnaire 6 months
Secondary Change from baseline in opioid equivalent medication usage in each group 6 months
Secondary Neurological assessment Assessment of motor, sensory and reflex functions. Clinicians shall characterize the findings as improved, maintained, or a deficit as compared with baseline status. 3, 6 and 12 months
Secondary Incidences of adverse events 3, 6 and 12 months
See also
  Status Clinical Trial Phase
Completed NCT05982483 - Erector Spinae Plane Block vs. Usual Care for ED Patients With Mechanical Back Pain N/A
Completed NCT04744246 - Muscle Activity During Load Carriage in ROTC Cadets N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Completed NCT05597189 - Clinical Study for Palliative/Preventive Treatment of Chronic Back Pain N/A
Completed NCT05342181 - Static and Dynamic Core Stability Exercises in Potpartum Back Pain N/A
Completed NCT02955342 - Back and Neck Pain in Adolescence
Completed NCT02704845 - Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain N/A
Not yet recruiting NCT02536274 - "Examination of the Impact of a Dynamic Flexion Orthosis (Dynaflex®Ottobock) or of a Back Bandage (Lumbo Sensa®Ottobock) on the Voluntary Activation of the Back Muscles in Patients With Specific Back Pain" N/A
Recruiting NCT02237105 - The Effect of Cognitive Behavioral Therapy on the Outcome of Spinal Surgery N/A
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Completed NCT02609009 - Back Pain and Spinal Manipulation in Adolescent Scoliosis N/A
Completed NCT02254694 - The Influence of High Heeled Shoes on the Sagittal Balance of the Spine and Whole Body N/A
Terminated NCT02239627 - Epidural Clonidine Versus Corticosteroid for Low Back Pain N/A
Completed NCT00986180 - NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain Phase 3
Terminated NCT00769626 - Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy Phase 3
Completed NCT00771758 - Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis Phase 3
Withdrawn NCT00231374 - Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning N/A
Completed NCT00103675 - Sensor Measurement of Acupuncture Needle Manipulation Phase 1
Completed NCT00454064 - Cognitive-behavioural Treatment of Chronic Back Pain Phase 3
Completed NCT04976738 - A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Phase 1/Phase 2